The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...

Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

About 200 people with the condition will be recruited for the trial, which will start in 2025. Read more at straitstimes.com.

Sanofi's $595m Singapore facility, Modulus, leverages advanced technology for rapid, flexible vaccine production, bolstering ...

SANOFI added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...

The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days. It will contribute about 200 skilled jobs to Singapore, and will be fully ...

The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days. It will contribute about 200 skilled jobs to Singapore, and will be fully ...